23andMe and its user data will soon belong to a pharmaceutical giant
23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech company Regeneron...
23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech company Regeneron...